➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Colorcon
Dow
Harvard Business School
McKesson

Last Updated: September 22, 2021

DrugPatentWatch Database Preview

Investigational Drug Information for Darinaparsin


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Darinaparsin?

Darinaparsin is an investigational drug.

There have been 12 clinical trials for Darinaparsin. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2007.

The most common disease conditions in clinical trials are Lymphoma, Lymphoma, T-Cell, Peripheral, and Lymphoma, T-Cell. The leading clinical trial sponsors are Ziopharm, Solasia Pharma K.K., and Synex Consulting Korea Ltd.

Recent Clinical Trials for Darinaparsin
TitleSponsorPhase
A Phase 2 Study of SP-02L in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)Solasia Pharma K.K.Phase 2
A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) in KoreaSynex Consulting Korea Ltd.Phase 1
A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) in KoreaSolasia Pharma K.K.Phase 1

See all Darinaparsin clinical trials

Clinical Trial Summary for Darinaparsin

Top disease conditions for Darinaparsin
Top clinical trial sponsors for Darinaparsin

See all Darinaparsin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
McKinsey
Mallinckrodt
Moodys
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.